| mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
3e-10 |
| mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-07 |
| mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
5e-07 |
| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
1e-06 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-06 |
| mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-06 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
7e-06 |
| mRNA |
GMX-1778 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-05 |
| mRNA |
KHS101 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-05 |
| mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |